Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults

The emergence of Omicron variants coincided with declining vaccine-induced protection against SARS-CoV-2. Two bivalent mRNA vaccines, mRNA-1273.222 (Moderna) and BNT162b2 Bivalent (Pfizer-BioNTech), were developed to provide greater protection against the predominate circulating variants by includin...

Descripción completa

Detalles Bibliográficos

Autores principales:	Hagit Kopel, Van Hung Nguyen, Catherine Boileau, Alina Bogdanov, Isabelle Winer, Thierry Ducruet, Ni Zeng, Mac Bonafede, Daina B. Esposito, David Martin, Andrew Rosen, Nicolas Van de Velde, Sten H. Vermund, Stefan Gravenstein, James A. Mansi
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2023-11-01
Colección:	Vaccines
Materias:	mRNA-1273.222 BNT162b2 Bivalent vaccine bivalent vaccine COVID-19 vaccine hospitalization symptomatic disease
Acceso en línea:	https://www.mdpi.com/2076-393X/11/11/1711
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!